Search

Your search keyword '"Boston Scientific Corp. -- Product development"' showing total 312 results
Start Over Descriptor "Boston Scientific Corp. -- Product development"
312 results on '"Boston Scientific Corp. -- Product development"'

151. Boston Scientific Begins Clinical Trial of ACUITY™ X4 LV Pacing Leads and RELIANCE™ 4-FRONT ICD Leads

Subjects
United States. Food and Drug Administration, Boston Scientific Corp. -- Product development, Medical test kit industry -- Product development, Medical equipment and supplies industry -- Product development, Clinical trials, Health
Abstract

By a News Reporter-Staff News Editor at Clinical Trials Week -- Boston Scientific Corporation (NYSE: BSX) has conducted the first implant in the clinical trial of the next generation ACUITY™ [...]

Published
2014

152. Corautus cancels trial, cuts executives

Subjects
Corautus Genetics Inc. -- Product development, Boston Scientific Corp. -- Product development, Biotechnology industry -- Product development, Medical equipment and supplies industry -- Product development, Medical test kit industry -- Product development, Business, Business, international
Abstract

(From AFX Europe (Focus)) ATLANTA (AFX) - Biopharmaceutical company Corautus Genetics Inc. said late Friday it is canceling further clinical trials on its vascular disease treatment candidate and its two [...]

Published
2006

153. Once-quiet device makers rule life-sciences roost

Author

Heuser, Stephen

Subjects
Boston Scientific Corp. -- Company sales and earnings, Boston Scientific Corp. -- Rankings, Boston Scientific Corp. -- Product development, Implantable cardioverter-defibrillators -- Marketing, Medical equipment and supplies industry -- Economic aspects, Medical equipment and supplies industry -- Rankings, Medical test kit industry -- Economic aspects, Medical test kit industry -- Rankings, Company earnings/profit, Company marketing practices, Business, Business, regional, General interest
Abstract

May 16--For years, medical devices took a quiet support role alongside high-flying drug manufacturing and biotechnology industries known for rolling out new $1 billion-a-year products. Suddenly that's no longer true, [...]

Published
2006

154. Gamble wins big at Boston Scientific

Author

Kerber, Ross

Subjects
Boston Scientific Corp. -- Company sales and earnings, Boston Scientific Corp. -- Product development, Stent (Surgery) -- Product development, Medical equipment and supplies industry -- Company sales and earnings, Medical equipment and supplies industry -- Product development, Medical test kit industry -- Company sales and earnings, Medical test kit industry -- Product development, Company earnings/profit, Business, Business, regional, General interest
Abstract

May 17--Boston Scientific Corp. didn't just have a great year. It also managed to avoid what could have been a disaster year. Posting a whopping 62 percent increase in revenue, [...]

Published
2005

155. Taxus Express(2) paclitaxel-eluting coronary stent system

Subjects
Boston Scientific Corp. -- Product development, Taxus Express(2) (Medical instrument) -- Licensing, certification and accreditation, Medical equipment and supplies industry -- Product development, Medical test kit industry -- Product development, Stent (Surgery) -- Licensing, certification and accreditation
Abstract

Boston Scientific Corp., Natick, Mass., (888) 272-1001, has the FDA's approval to extend the shelf life of its Taxus Express(2) paclitaxel-eluting coronary stent system to 18 months in the United [...]

Published
2007

156. Cold-hearted remedy

Subjects
Boston Scientific Corp. -- Product development, Medical equipment and supplies industry -- Product development, Medical test kit industry -- Product development, Business, Chemicals, plastics and rubber industries
Published
2006

157. Boston reinforces clinical evidence to support Taxus platform

Subjects
Boston Scientific Corp. -- Product development, Stent (Surgery) -- Product development, Medical equipment and supplies industry -- Product development, Medical test kit industry -- Product development, Business, Health care industry, Pharmaceuticals and cosmetics industries, Taxus (Medical instrument) -- Product development, Taxus Liberte (Medical instrument) -- Product development
Abstract

The clinical data for Boston Scientific's paclitaxel-eluting stent, Taxus and its next generation drug eluting stent, Taxus Liberte, are discussed.

Published
2005

158. Boston gets US nod for Liberte stent, firm pits DES versus bypass

Subjects
United States. Food and Drug Administration -- Licensing, certification and accreditation, Boston Scientific Corp. -- Product development, Boston Scientific Corp. -- Research, Stent (Surgery) -- Licensing, certification and accreditation, Stent (Surgery) -- Comparative analysis, Medical equipment and supplies industry -- Product development, Medical equipment and supplies industry -- Research, Medical test kit industry -- Product development, Medical test kit industry -- Research, Heart -- Surgery, Heart -- Comparative analysis, Business, Health care industry, Pharmaceuticals and cosmetics industries
Abstract

The Food and Drug Administration's approval to Boston Scientific for selling its new bare metal coronary stent Liberte is discussed. The firm is also doing research over comparing drug-eluting stents with heart bypass surgery in patients with severest form of coronary artery disease.

Published
2005

159. Boston Scientific Reports Favorable Clinical Trial Results Assessing The OffRoad Re-Entry Catheter System

Subjects
Boston Scientific Corp. -- Product development, Medical test kit industry -- Product development, Medical equipment and supplies industry -- Product development, Clinical trials, Biotechnology industry, Biological sciences, Business, Product development
Abstract

By a News Reporter-Staff News Editor at Biotech Business Week -- The Boston Scientific (NYSE: BSX) OffRoad™ Re-Entry Catheter System demonstrated excellent performance in facilitating the treatment of complete blockages [...]

Published
2013

160. Boston Scientific Begins Clinical Trial Of Innova Peripheral Vascular Drug-Eluting Stent System

Subjects
Boston Scientific Corp. -- Product development, Stent (Surgery) -- Product development, Medical test kit industry -- Product development, Medical equipment and supplies industry -- Product development, Clinical trials, Biotechnology industry, Biological sciences, Business, Product development
Abstract

By a News Reporter-Staff News Editor at Biotech Business Week -- Launching a key clinical trial expected to serve as the foundation for global regulatory approvals, a physician in Auckland, [...]

Published
2013

161. Boston Scientific Begins Patient Enrollment In U.S. Clinical Trial For Use Of Vercise DBS System In Treatment Of Parkinson's Disease

Subjects
Boston Scientific Corp. -- Product development, Medical test kit industry -- Product development -- Usage, Direct broadcast satellite television industry -- Product development -- Usage, Extrapyramidal disorders -- Drug therapy -- Usage, Medical equipment and supplies industry -- Product development -- Usage, Clinical trials -- Usage, Health
Abstract

By a News Reporter-Staff News Editor at Clinical Trials Week -- Boston Scientific Corporation (NYSE: BSX) announces the first implantation of its Vercise™ DBS System as part of the INTREPID [...]

Published
2013

162. Boston Scientific: Patient Enrollment Open in U.S. Clinical Trial for Use of Vercise DBS System

Subjects
Boston Scientific Corp. -- Product development, Medical test kit industry -- Product development -- Usage, Direct broadcast satellite television industry -- Product development -- Usage, Medical equipment and supplies industry -- Product development -- Usage, Clinical trials -- Usage, Business, Business, international, Telecommunications industry
Abstract

Boston Scientific Corp. announced the first implantation of its Vercise DBS System as part of the Intrepid clinical trial. According to a release, Intrepid is a prospective, multi-center, double-blinded, randomized, [...]

Published
2013

163. Boston Scientific Begins Clinical Trial To Evaluate New Pacing System in MRI Environment

Subjects
Boston Scientific Corp. -- Product development, Medical test kit industry -- Product development, Magnetic resonance imaging, Medical equipment and supplies industry -- Product development, Clinical trials, Pharmaceuticals and cosmetics industries
Abstract

By a News Reporter-Staff News Editor at Drug Week -- The first patient in the United States has been implanted with the Boston Scientific Corporation (NYSE: BSX) next generation ImageReady™ [...]

Published
2013

164. Presentation of Preliminary Results From Boston Scientific PREVAIL Clinical Trial Now Available

Subjects
Boston Scientific Corp. -- Product development, Medical test kit industry -- Product development, Medical equipment and supplies industry -- Product development, Clinical trials, Health, American College of Cardiology
Abstract

By a News Reporter-Staff News Editor at Clinical Trials Week -- Boston Scientific Corporation (NYSE: BSX) announces the preliminary analysis of the PREVAIL clinical trial data is now available on [...]

Published
2013

165. Boston Scientific Updates PREVAIL Late Breaking Clinical Trials Presentation

Subjects
Boston Scientific Corp. -- Product development, Medical test kit industry -- Product development, Medical equipment and supplies industry -- Product development, Clinical trials, Health
Abstract

By a News Reporter-Staff News Editor at Clinical Trials Week -- The Boston Scientific Corporation (NYSE: BSX) PREVAIL clinical trial results will be presented in a Late-Breaking Clinical Trial presentation [...]

Published
2013

166. First Patient Treated In The Boston Scientific ZERO AF Clinical Trial To Evaluate The Safety And Performance Of The Blazer[R] Open-Irrigated Temperature Ablation Catheter

Subjects
Boston Scientific Corp. -- Product development, Medical test kit industry -- Product development, Atrial fibrillation, Ablation (Surgery), Medical equipment and supplies industry -- Product development, Clinical trials, Health
Abstract

By a News Reporter-Staff News Editor at Clinical Trials Week -- The first patient has been treated in the Boston Scientific Corporation (NYSE: BSX) ZERO AF clinical trial to evaluate [...]

Published
2013

167. Taxus Express2

Subjects
United States. Food and Drug Administration -- Standards, Taxus Express2 (Medication) -- Licensing, certification and accreditation, Medical equipment and supplies industry -- Product development, Stent (Surgery) -- Licensing, certification and accreditation, Boston Scientific Corp. -- Product development
Abstract

FDA approved extending the shelf-life of the paclitaxel-eluting coronary stent (Taxus Express2, Boston Scientific) from six months to nine […]

Published
2004

168. Coated stents deliver heartburn; clot risks dash investor hopes for artery-opening devices as market is set to get crowded

Author

Johnson, Avery

Subjects
Johnson & Johnson -- Product development, Johnson & Johnson -- Securities, Johnson & Johnson -- Forecasts and trends, Boston Scientific Corp. -- Product development, Boston Scientific Corp. -- Securities, Boston Scientific Corp. -- Forecasts and trends, Abbott Laboratories (Abbott Park, Illinois) -- Product development, Abbott Laboratories (Abbott Park, Illinois) -- Securities, Abbott Laboratories (Abbott Park, Illinois) -- Forecasts and trends, Stent (Surgery) -- Product development, Stent (Surgery) -- Economic aspects, Stent (Surgery) -- Safety and security measures, Pharmaceutical industry -- Product development, Pharmaceutical industry -- Securities, Pharmaceutical industry -- Forecasts and trends, Pharmaceutical industry -- Safety and security measures, Medical equipment and supplies industry -- Product development, Medical equipment and supplies industry -- Securities, Medical equipment and supplies industry -- Forecasts and trends, Medical equipment and supplies industry -- Safety and security measures, Medical test kit industry -- Product development, Medical test kit industry -- Securities, Medical test kit industry -- Forecasts and trends, Medical test kit industry -- Safety and security measures, Company securities, Market trend/market analysis, News, opinion and commentary
Published
2006

169. Boston Scientific Begins Clinical Trial of Patients Implanted with INGEVITY Pacing Leads

Subjects
Boston Scientific Corp. -- Product development, Medical test kit industry -- Product development, Prosthesis -- Product development, Implants, Artificial -- Product development, Medical equipment and supplies industry -- Product development, Clinical trials, Biotechnology industry, Biological sciences, Business
Abstract

By a News Reporter-Staff News Editor at Biotech Business Week -- The first patient has been implanted with the Boston Scientific Corporation (NYSE: BSX) next generation INGEVITY™ pacing leads in [...]

Published
2012

170. First Patient Enrolled in REPRISE II TAVR Clinical Trial to Evaluate the Safety and Performance of the Lotus Valve System

Subjects
Boston Scientific Corp. -- Product development, Medical test kit industry -- Product development, Medical equipment and supplies industry -- Product development, Clinical trials, Biotechnology industry, Biological sciences, Business
Abstract

By a News Reporter-Staff News Editor at Biotech Business Week -- Boston Scientific (NYSE: BSX) has enrolled the first patient in the REPRISE II clinical trial to evaluate the safety [...]

Published
2012

171. One-Year EVOLVE Trial Clinical Results Confirm Safety

Subjects
Boston Scientific Corp. -- Product development, Stent (Surgery) -- Product development, Medical test kit industry -- Product development, Medical equipment and supplies industry -- Product development, Biotechnology industry, Business
Abstract

Boston Scientific Corporation (NYSE: BSX), Natick, Mass., announces that the SYNERGY Everolimus-Eluting Bioabsorbable Polymer-Coated Platinum Chromium Coronary Stent System demonstrated non-inferior results in treating de novo coronary artery lesions at [...]

Published
2012

172. One-Year EVOLVE Trial Clinical Results Confirm Comparable Safety And Effectiveness Data Of The Boston Scientific SYNERGY Stent Versus PROMUS Element Platinum Chromium Stent

Subjects
Boston Scientific Corp. -- Product development, Stent (Surgery) -- Product development, Medical test kit industry -- Product development, Biotechnology industry -- Product development, Medical equipment and supplies industry -- Product development, Biotechnology industry, Pharmaceuticals and cosmetics industries
Abstract

By a News Reporter-Staff News Editor at Biotech Week -- Boston Scientific Corporation (NYSE: BSX) announces that the SYNERGY™ Everolimus-Eluting Bioabsorbable Polymer-Coated Platinum Chromium Coronary Stent System demonstrated non-inferior results [...]

Published
2012

173. Boston Scientific Completes Enrollment in Clinical Trial to Evaluate Lotus Aortic Valve System

Subjects
Boston Scientific Corp. -- Product development, Medical test kit industry -- Product development, Medical equipment and supplies industry -- Product development, Clinical trials, Aortic valve stenosis, Heart valve diseases, Health, Health care industry
Abstract

Boston Scientific Corporation (NYSE: BSX) announces that it has completed enrollment in the REPRISE I clinical trial, which is designed to evaluate the acute safety of the Lotus™ Aortic Valve [...]

Published
2012

174. The Cardiovascular Research Foundation announces initiation of HORIZONS-AMI II Clinical Trial

Subjects
Boston Scientific Corp. -- Product development, Heart attack -- Research, Medical research, Medicine, Experimental, Stent (Surgery) -- Product development, Medical test kit industry -- Product development, Medical equipment and supplies industry -- Product development, Clinical trials, Cardiac patients, Health
Abstract

CHICAGO, IL - The Cardiovascular Research Foundation (CRF) announced the initiation of the HORIZONS-AMI II randomized trial, evaluating Promus Element platinum-chromium everolimus-eluting stents versus Omega bare-metal stents in patients with [...]

Published
2012

175. Boston Scientific Supports New Clinical Trial to Evaluate Platinum Chromium Coronary Stents in Treating Heart Attack Patients

Subjects
Boston Scientific Corp. -- Product development, Heart attack, Cardiology, Stent (Surgery) -- Product development, Medical test kit industry -- Product development, Medical equipment and supplies industry -- Product development, Clinical trials, Cardiac patients, Health
Abstract

Boston Scientific Corporation (NYSE: BSX) announces its support of the HORIZONS II AMI clinical trial, which is designed to evaluate the safety and efficacy of the PROMUS Element™ Plus Everolimus-Eluting [...]

Published
2012

176. Analysis of Two Randomized Clinical Trials Identify No Cases of Longitudinal Stent Deformation With Boston Scientific Platinum Chromium Stents

Subjects
Boston Scientific Corp. -- Product development, Stent (Surgery) -- Product development, Medical test kit industry -- Product development, Medical equipment and supplies industry -- Product development, Clinical trials, Cardiac patients, Health
Abstract

Boston Scientific Corporation (NYSE: BSX) announces results from a quantitative coronary angiographic (QCA) analysis of the incidence of longitudinal stent deformation in the PERSEUS and PLATINUM randomized clinical trials, comprising [...]

Published
2012

177. Boston buoyed by drug-coated stent data

Subjects
Boston Scientific Corp. -- Testing, Boston Scientific Corp. -- Product development, Medical equipment and supplies industry -- Product development, Medical equipment and supplies industry -- Testing, Stent (Surgery) -- Product development, Stent (Surgery) -- Testing, Cardiovascular instruments, Implanted -- Product development, Cardiovascular instruments, Implanted -- Testing, Business, Health care industry, Pharmaceuticals and cosmetics industries
Abstract

The clinical trial of Boston Scientific's paclitaxel-eluting stent has produced positive results. Data show that the stent is effective in preventing coronary artery reblockage after angioplasty. Restenosis, or scar tissue buildup around the stent, was under 5% for the trial.

Published
2002

178. Boston pushes ahead with atrial flutter ablation tech

Subjects
Boston Scientific Corp. -- Product development, Medical equipment and supplies industry -- Product development, Business, Health care industry, Pharmaceuticals and cosmetics industries
Abstract

Boston Scientific Corp. is closing in on final premarket approval of its radiofrequency cardiac ablation system. It is used to treat atrial flutter, a cause of heart failure and stroke. The Food and Drug Administration is reviewing the technology for market.

Published
2002

179. Boston's paclitaxel-eluting stent shows in-stent promise

Subjects
Boston Scientific Corp. -- Product development, Medical equipment and supplies industry -- Product development, Business, Health care industry, Pharmaceuticals and cosmetics industries
Abstract

Boston Scientific reports clinical trials for its TAXUS III treatment shows promising results. The drug is a paclitaxel-eluting stent and will be used as a treatment for in-stent restenosis.

Published
2002

180. Boston Scientific Completes Enrollment in Benign Stricture Study of WallFlex[R] Biliary RX Stent

Subjects
Boston Scientific Corp. -- Product development, Stent (Surgery) -- Product development -- Research, Medical test kit industry -- Product development -- Research, Medical equipment and supplies industry -- Product development -- Research, Clinical trials -- Research, Health
Abstract

Boston Scientific Corporation (NYSE: BSX) has completed enrollment in a clinical trial to evaluate its WallFlex® Biliary RX Fully Covered Stent for the treatment of benign bile duct strictures (narrowing [...]

Published
2011

181. Boston Scientific completes enrollment in WallFlex Biliary RX Stent study

Subjects
Boston Scientific Corp. -- Product development, Stent (Surgery) -- Product development -- Research, Medical test kit industry -- Product development -- Research, Medical equipment and supplies industry -- Product development -- Research, Clinical trials -- Research, Chemistry
Abstract

M2 PHARMA-October 19, 2011-Boston Scientific completes enrollment in WallFlex Biliary RX Stent study(C)2011 M2 COMMUNICATIONS 19 October 2011 - US medical devices maker Boston Scientific Corp (NYSE:BSX) said yesterday that [...]

Published
2011

182. Boston Scientific Begins Clinical Trial Enrollment for OMEGA Platinum Chromium Stent System

Subjects
Boston Scientific Corp. -- Product development, Stent (Surgery) -- Product development, Medical test kit industry -- Product development, Medical equipment and supplies industry -- Product development, Clinical trials, Cardiac patients, Health
Abstract

Boston Scientific Corporation (NYSE: BSX) has started patient enrollment in the OMEGA clinical trial, designed to evaluate the safety and effectiveness of the Company's OMEGA™ Platinum Chromium Bare-Metal Coronary Stent [...]

Published
2011

183. Boston Scientific Begins Enrollment in NECTAR-HF Clinical Trial

Subjects
Boston Scientific Corp. -- Product development, Cardiovascular agents -- Product development, Medical test kit industry -- Product development, Medical equipment and supplies industry -- Product development, Clinical trials, Cardiac patients, Heart failure, Health
Abstract

Boston Scientific Corporation (NYSE: BSX) has enrolled the first patients in its NECTAR-HF (NEural Cardiac TherApy foRHeart Failure) clinical trial. NECTAR-HF is a prospective, randomized, international clinical feasibility study designed [...]

Published
2011

184. Boston Scientific starts enrollment in NECTAR-HF trial

Subjects
Boston Scientific Corp. -- Product development, Cardiovascular agents -- Product development, Medical test kit industry -- Product development, Medical equipment and supplies industry -- Product development, Clinical trials, Cardiac patients, Chemistry
Abstract

M2 PHARMA-September 30, 2011-Boston Scientific starts enrollment in NECTAR-HF trial(C)2011 M2 COMMUNICATIONS 30 September 2011 - US medical devices maker Boston Scientific Corp (NYSE:BSX) said yesterday it had enrolled the [...]

Published
2011

185. Boston Scientific Begins International Clinical Trial Enrollment for INNOVA Self-Expanding Bare-Metal Stent System

Subjects
Boston Scientific Corp. -- Product development, Stent (Surgery) -- Product development, Medical test kit industry -- Product development, Medical equipment and supplies industry -- Product development, Clinical trials, Advertising, marketing and public relations
Abstract

Boston Scientific Corporation (NYSE: BSX) announced the start of patient enrollment in the SuperNOVA clinical trial, an international, prospective, single-arm, non-randomized trial evaluating the safety and effectiveness of the INNOVA™ [...]

Published
2011

186. Boston Scientific Completes Enrollment in EVOLVE Clinical Trial to Evaluate SYNERGY Drug-Eluting Coronary Stent

Subjects
Boston Scientific Corp. -- Product development, Stent (Surgery) -- Product development, Medical test kit industry -- Product development, Medical equipment and supplies industry -- Product development, Clinical trials, Cardiac patients, Health
Abstract

Boston Scientific Corporation (NYSE: BSX) announced the completion of patient enrollment in the EVOLVE clinical trial, which is designed to assess the safety and performance of the Company's fourth-generation SYNERGY™ [...]

Published
2011

187. Boston Scientific starts use of Blazer Open-Irrigated Catheter in US trial

Subjects
Boston Scientific Corp. -- Product development, Medical equipment -- Product development, Medical test kit industry -- Product development, Arrhythmia, Medical equipment and supplies industry -- Product development, Clinical trials, Physiological apparatus -- Product development, Chemistry
Abstract

M2 PHARMA-January 28, 2011-Boston Scientific starts use of Blazer Open-Irrigated Catheter in US trial(C)2011 M2 COMMUNICATIONS 28 January 2011 - US-based medical devices maker Boston Scientific Corp (NYSE: BSX) announced [...]

Published
2011

188. Boston Scientific Completes Enrollment in Clinical Trial Evaluating Next-Generation Nitinol Stent to Treat Iliac Artery Disease

Subjects
Boston Scientific Corp. -- Product development, Stent (Surgery) -- Evaluation -- Product development, Medical test kit industry -- Product development, Nickel alloys -- Evaluation -- Product development, Medical equipment and supplies industry -- Product development, Clinical trials, Health
Abstract

Boston Scientific Corporation (NYSE: BSX) announced that it has completed enrollment in the ORION clinical trial, which is designed to evaluate the Company's EPIC™ Self-Expanding Nitinol Stent System for the [...]

Published
2011

189. Boston Scientific completes enrollment in Nitinol Stent trial for treatment of iliac artery disease

Subjects
Boston Scientific Corp. -- Product development, Stent (Surgery) -- Product development, Medical test kit industry -- Product development, Medical equipment and supplies industry -- Product development, Clinical trials, Chemistry
Abstract

M2 PHARMA-January 11, 2011-Boston Scientific completes enrollment in Nitinol Stent trial for treatment of iliac artery disease(C)2011 M2 COMMUNICATIONS 11 January 2011 - US medical devices maker Boston Scientific Corp [...]

Published
2011

190. Boston Scientific Corporation Receives FDA Approval For The Magic Wallstent

Subjects
Boston Scientific Corp. -- Product development, schneider worldwide -- Mergers, acquisitions and divestments, Medical equipment and supplies industry -- Product development, Business, News, opinion and commentary
Abstract

NATICK, Mass. Sept. 30 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) announced today that the U.S. Food & Drug Administration (FDA) has approved the Magic Wallstent for the treatment of [...]

Published
1998

191. Boston Scientific Begins Patient Enrollment in Clinical Trial Assessing Deep Brain Stimulation for Parkinson's Disease

Subjects
Boston Scientific Corp. -- Product development, Medical research, Medicine, Experimental, Medical test kit industry -- Product development, Extrapyramidal disorders, Medical equipment and supplies industry -- Product development, Parkinson's disease, Clinical trials, Health, Parkinson's Disease Foundation
Abstract

Boston Scientific Corporation (NYSE: BSX) announced the first implantation of its Vercise™ Deep Brain Stimulation (DBS) System as part of the VANTAGE clinical trial. VANTAGE is a multi-center, prospective trial [...]

Published
2010

192. TRIAL ENROLLMENT FOR CORONARY STENT WITH POLYMER

Subjects
Boston Scientific Corp. -- Product development, Stent (Surgery) -- Product development, Medical test kit industry -- Product development, Polymer industry -- Product development, Medical equipment and supplies industry -- Product development, Clinical trials, Biotechnology industry, Business
Abstract

Boston Scientific Corporation (NYSE: BSX) has announced the start of patient enrollment in the EVOLVE clinical trial, which is designed to assess the safety and performance of its fourth-generation SYNERGY(TM) [...]

Published
2010

193. Boston Scientific Begins Clinical Trial Enrollment for New Coronary Stent with Bioabsorbable Polymer and Everolimus Drug Coating

Subjects
Boston Scientific Corp. -- Product development, Stent (Surgery) -- Product development, Medical test kit industry -- Product development, Medical equipment and supplies industry -- Product development, Clinical trials, Angiogenesis inhibitors, Health
Abstract

Boston Scientific Corporation (NYSE:BSX) announced the start of patient enrollment in the EVOLVE clinical trial, which is designed to assess the safety and performance of its fourth-generation SYNERGY™ Coronary Stent. [...]

Published
2010

194. Boston Scientific Announces First Patient Enrollment in MultiSENSE Clinical Trial

Subjects
Boston Scientific Corp. -- Product development, Medical research, Medicine, Experimental, Medical test kit industry -- Product development, Medical equipment and supplies industry -- Product development, Clinical trials, Heart failure, Pharmaceuticals and cosmetics industries
Abstract

Boston Scientific Corporation (NYSE:BSX) announced enrollment of the first patient in its MultiSENSE clinical trial. The trial is designed to evaluate multiple physiologic sensors in the Company's COGNIS™ cardiac resynchronization [...]

Published
2010

195. Boston Scientific Begins Platinum Plus Trial for Promus[R] Element Stent System

Subjects
Boston Scientific Corp. -- Product development, Stent (Surgery) -- Product development, Medical test kit industry -- Product development, Medical equipment and supplies industry -- Product development, Clinical trials, Transition metals, Chromium alloys -- Product development, Health
Abstract

Boston Scientific Corporation (NYSE:BSX) announced the initiation of the PLATINUM PLUS clinical trial, an investigator-sponsored research (ISR) study designed to compare the performance of the PROMUS® Element™ Everolimus-Eluting Coronary Stent [...]

Published
2010

196. Boston Scientific initiates PLATINUM PLUS trial for PROMUS Element Stent System

Subjects
Boston Scientific Corp. -- Product development, Stent (Surgery) -- Product development, Medical test kit industry -- Product development, Medical equipment and supplies industry -- Product development, Clinical trials, Chemistry
Abstract

M2 EUROPHARMA-(C)1999-2010 M2 COMMUNICATIONS 26 May 2010 - US-based medical devices company Boston Scientific Corporation (NYSE: BSX) today announced the initiation of the PLATINUM PLUS clinical trial, an investigator-sponsored research [...]

Published
2010

197. Boston Scientific Begins Groundbreaking Clinical Trial Comparing Spinal Cord Stimulation to Spine Reoperation In Patients With Failed Back Surgery Syndrome

Subjects
Boston Scientific Corp. -- Product development, Medical test kit industry -- Product development, Medical equipment and supplies industry -- Product development, Clinical trials, Surgery, Health
Abstract

Boston Scientific Corporation (NYSE:BSX) announced the start of patient enrollment in the EVIDENCE Clinical Trial, which compares the therapeutic effectiveness and cost effectiveness of spinal cord stimulation (SCS) therapy to [...]

Published
2010

198. FDA Advisory Panel Unanimously Recommends Expanded Indication for Boston Scientific's Heart Failure Devices Based on Landmark MADIT-CRT Trial

Subjects
Boston Scientific Corp. -- Product development, Heart block, Medical test kit industry -- Product development, Medical equipment and supplies industry -- Product development, Clinical trials, Cardiac patients, Heart failure, Biotechnology industry, Pharmaceuticals and cosmetics industries, Health
Abstract

Boston Scientific Corporation (NYSE:BSX) announced that the Circulatory System Devices Panel of the U.S. Food and Drug Administration (FDA) has unanimously recommended approval of an expanded indication for its cardiac [...]

Published
2010

199. Boston Scientific Announces Enrollment of First Patient in Benign Stricture Study of WallFlex Biliary RX Stent

Subjects
Boston Scientific Corp. -- Product development, Transplantation of organs, tissues, etc. -- Research, Medical research, Medicine, Experimental, Stent (Surgery) -- Product development -- Research, Medical test kit industry -- Product development -- Research, Medical equipment and supplies industry -- Product development -- Research, Clinical trials -- Research, Health
Abstract

Boston Scientific Corporation (NYSE:BSX) announced that the first patient has been enrolled in a clinical trial to evaluate its WallFlex® Biliary RX Fully Covered Stent for the treatment of benign [...]

Published
2010

200. Boston Scientific Announces Exclusive Sponsorship and First Enrollments of MADIT-RIT Clinical Trial

Subjects
Medical test kit industry -- Product development, Medical equipment and supplies industry -- Product development, Clinical trials, Cardiac patients, Boston Scientific Corp. -- Product development
Abstract

Boston Scientific Corporation (NYSE:BSX) announced its exclusive sponsorship and first enrollments of the MADIT-RIT clinical trial. This new trial follows in the tradition of three previous landmark trials: MADIT, MADIT [...]

Published
2009

Catalog

Books, media, physical & digital resources
See catalog results